tiprankstipranks
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ:GLUE
US Market
GLUE
Monte Rosa Therapeutics
RESEARCH TOOLSreports

Monte Rosa Therapeutics (GLUE) Stock News & Sentiment

382 Followers
GLUE Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
GLUE Earnings this Week: How Will it Perform?
1M ago
GLUE
Monte Rosa Therapeutics Prices $300 Million Public Offering
Premium
Company Announcements
Monte Rosa Therapeutics Prices $300 Million Public Offering
3M ago
8K
GLUE
Monte Rosa Therapeutics Ends Current ATM Equity Program
Premium
Company Announcements
Monte Rosa Therapeutics Ends Current ATM Equity Program
3M ago
8K
GLUE
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
3M ago
AAL
AMD
Here’s Why Monte Rosa Therapeutics Stock (GLUE) Rocketed Today
Premium
Market News
Here’s Why Monte Rosa Therapeutics Stock (GLUE) Rocketed Today
3M ago
GLUE
Monte Rosa Therapeutics: Early MRT-8102 hsCRP Data Underscore Differentiated NLRP3 Opportunity and Attractive Risk-Reward Supporting Buy Rating
Premium
Ratings
Monte Rosa Therapeutics: Early MRT-8102 hsCRP Data Underscore Differentiated NLRP3 Opportunity and Attractive Risk-Reward Supporting Buy Rating
3M ago
GLUE
Monte Rosa reports positive Phase 1 data for MRT-8102
Premium
Company Announcements
Monte Rosa reports positive Phase 1 data for MRT-8102
3M ago
8K
GLUE
More GLUE News >

GLUE News on the Web

Top Monte Rosa Therapeutics Executive Makes Notable Insider Stock Move
TipRanks News
Neutral
Insider Sell: Philip Nickson Sells Shares of Monte Rosa Therapeutics Inc (GLUE)
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Monte Rosa Therapeutics (GLUE) and Curis (CRIS)
TipRanks News
Bullish
J.P. Morgan Keeps Their Buy Rating on Monte Rosa Therapeutics (GLUE)
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Lantheus (LNTH) and Monte Rosa Therapeutics (GLUE)
TipRanks News
Neutral
Monte Rosa Therapeutics price target lowered to $30 from $34 at Guggenheim
TipRanks News
Bearish
Wells Fargo Sticks to Its Buy Rating for Monte Rosa Therapeutics (GLUE)
TipRanks News
Neutral
Decoding Monte Rosa Therapeutics Inc (GLUE): A Strategic SWOT Insight
GuruFocus News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
GLUE
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GLUE’s Media Buzz Sentiment?
2 articles about GLUE were published this week. In an average week, 4.25 articles are published.
    What is GLUE’s weekly average amount of articles?
    In an average week, 4.25 articles about GLUE are published.
      What is GLUE’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      AORTArtivion
      NBIXNeurocrine
      STAAStaar Surgical
      SLPSimulations Plus
      OWLTOwlet
      Showing the stocks with the most bullish news sentiment over the past week